logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Left Ventricular Dysfunction

    FiltersReset Filters
    5 results

    • enalapril maleate

      (enalapril maleate)
      NorthStar RxLLC
      Usage: Enalapril maleate tablets are indicated for treating hypertension, symptomatic congestive heart failure, and asymptomatic left ventricular dysfunction. They can be used alone or with other antihypertensives and have shown to improve symptoms, increase survival, and reduce hospitalizations in heart failure patients.

    • enalapril maleate

      (ENALAPRIL MALEATE)
      ScieGen Pharmaceuticals, Inc.
      Usage: Enalapril maleate tablets are indicated for treating hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction. They enhance blood pressure control, improve heart failure symptoms, and reduce hospitalization rates. Effectiveness may vary among different ethnic groups, with a noted higher incidence of angioedema in black patients.

    • valsartan

      (Valsartan)
      Viona Pharmaceuticals Inc
      Usage: Valsartan tablets are indicated for treating hypertension in adults and pediatric patients (1 year and older), reducing the risk of cardiovascular events. They are also used to decrease hospitalization risk in adult heart failure patients and to lower cardiovascular mortality in stable adults with left ventricular dysfunction after a myocardial infarction.

    • valsartan

      (VALSARTAN)
      Ohm Laboratories Inc.
      Usage: Valsartan is indicated for treating hypertension in adults and pediatric patients aged six and older, reducing cardiovascular event risks. It also helps prevent hospitalizations in adults with heart failure (NYHA class II-IV) and lowers cardiovascular mortality risk in stable patients post-myocardial infarction with left ventricular dysfunction.

    • valsartan

      (Valsartan)
      Aurobindo Pharma Limited
      Usage: Valsartan tablets are indicated for treating hypertension in adults and pediatric patients (one year and older) to lower blood pressure and reduce cardiovascular event risks. They are also used to reduce heart failure hospitalization in adults and decrease cardiovascular mortality risk in clinically stable patients post-myocardial infarction.